Literature DB >> 10807585

Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney.

V Murthy1, L A Haddad, N Smith, D Pinney, R Tyszkowski, D Brown, V Ramesh.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in multiple organs, notably the brain and kidneys. The disease is caused by mutations in TSC1 or TSC2 genes, coding hamartin and tuberin, respectively. Immunofluorescence analysis of tuberin and hamartin performed here demonstrates that both proteins are specifically expressed in the distal urinary tubule, comprising the distal tubules, connecting segment, and collecting ducts. Hamartin, distinct from tuberin, is expressed in the thick ascending limbs of Henle and in juxtaglomerular cells, where it colocalizes with renin. In positive epithelial cells, tuberin localizes to the cytoplasm as well as the apical membrane. Hamartin, however, preferentially localizes to the apical membrane. The two proteins colocalize at the apical membrane of type A intercalated cells and connecting tubule cells, whereas in type B intercalated cells they reveal a variable pattern of expression. The cell-specific expression of tuberin and hamartin described here will provide critical insight into the cell types that give rise to kidney lesions, and the tumor suppressor role of these proteins in TSC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807585     DOI: 10.1152/ajprenal.2000.278.5.F737

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Activation of mTORC1 in collecting ducts causes hyperkalemia.

Authors:  Zhenguo Chen; Heling Dong; Chunhong Jia; Qiancheng Song; Juan Chen; Yue Zhang; Pinglin Lai; Xiaorong Fan; Xuan Zhou; Miao Liu; Jun Lin; Cuilan Yang; Ming Li; Tianming Gao; Xiaochun Bai
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

2.  Tuberin--a new molecular target in Alzheimer's disease?

Authors:  Rosa Ferrando-Miguel; Margit Rosner; Angelika Freilinger; Gert Lubec; Markus Hengstschläger
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.

Authors:  Y Niida; A O Stemmer-Rachamimov; M Logrip; D Tapon; R Perez; D J Kwiatkowski; K Sims; M MacCollin; D N Louis; V Ramesh
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

Review 4.  Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Authors:  Stephen C Juvet; Francis X McCormack; David J Kwiatkowski; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-10       Impact factor: 6.914

5.  Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model.

Authors:  Shilpa Prabhakar; Xuan Zhang; June Goto; Sangyeul Han; Charles Lai; Roderick Bronson; Miguel Sena-Esteves; Vijaya Ramesh; Anat Stemmer-Rachamimov; David J Kwiatkowski; Xandra O Breakefield
Journal:  Neurobiol Dis       Date:  2015-05-24       Impact factor: 5.996

6.  Unilateral giant renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

Authors:  Fernando Peixoto Ferraz de Campos; Cristiane Rúbia Ferreira; Angélica Braz Simões; Paulo Sergio Martins de Alcântara; Brenda Margatho Martines; Adriano Ferreira da Silva; Deborah Azzi-Nogueira; Luiz Roberto Giorgetti de Britto; Luiz Gustavo Dufner-Almeida; Luciana Amaral Haddad
Journal:  Autops Case Rep       Date:  2013-12-31

7.  Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex.

Authors:  Sharon Barone; Kamyar Zahedi; Marybeth Brooks; Elizabeth P Henske; Yirong Yang; Erik Zhang; John J Bissler; Jane J Yu; Manoocher Soleimani
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.